Cancel anytime
NeueHealth Inc (NEUE)NEUE
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2024: NEUE (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Profit: -89.42% | Upturn Advisory Performance 1 | Avg. Invested days: 15 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/17/2024 |
Type: Stock | Today’s Advisory: PASS |
Profit: -89.42% | Avg. Invested days: 15 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/17/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 52.80M USD |
Price to earnings Ratio - | 1Y Target Price 24.33 |
Dividends yield (FY) - | Basic EPS (TTM) - |
Volume (30-day avg) 9297 | Beta 0.85 |
52 Weeks Range 4.69 - 16.59 | Updated Date 09/15/2024 |
Company Size Small-Cap Stock | Market Capitalization 52.80M USD | Price to earnings Ratio - | 1Y Target Price 24.33 |
Dividends yield (FY) - | Basic EPS (TTM) - | Volume (30-day avg) 9297 | Beta 0.85 |
52 Weeks Range 4.69 - 16.59 | Updated Date 09/15/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -99.2% | Operating Margin (TTM) -15.64% |
Management Effectiveness
Return on Assets (TTM) -3.58% | Return on Equity (TTM) -183.26% |
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 1366173312 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - |
Shares Outstanding 8224540 | Shares Floating 3354328 |
Percent Insiders 5.48 | Percent Institutions 63.61 |
Trailing PE - | Forward PE - | Enterprise Value 1366173312 | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding 8224540 | Shares Floating 3354328 |
Percent Insiders 5.48 | Percent Institutions 63.61 |
Analyst Ratings
Rating 2.5 | Target Price 24.33 | Buy - |
Strong Buy - | Hold 1 | Sell 1 |
Strong Sell - |
Rating 2.5 | Target Price 24.33 | Buy - | Strong Buy - |
Hold 1 | Sell 1 | Strong Sell - |
AI Summarization
NeueHealth Inc.: A Comprehensive Overview
Company Profile
History: NeueHealth Inc., also known as NH Inc., is a company focusing on developing and commercializing healthcare IT solutions. It primarily operates through its subsidiaries - HealthLine, Inc. and HealthLine Software, Inc. Founded in 1983, NeueHealth began as a provider of medical transcription services. However, over the years, it evolved into a technology-driven solutions provider for the healthcare industry.
Core Business Areas:
- Healthcare IT Solutions: NeueHealth offers a range of software solutions, including patient engagement tools, clinical documentation tools, telehealth platforms, and revenue cycle management services.
- Medical Transcription Services: While this was the initial offering, it now comprises a smaller portion of the business.
Leadership and Structure: NeueHealth is led by CEO M. Shane Woods and CFO Robert A. Long. The corporate structure consists of a Board of Directors, an executive team, and various departments responsible for different business functions.
Top Products and Market Share
Top Products:
- HealthLine® Patient Portal: A cloud-based platform offering patient engagement tools like appointment scheduling, secure messaging, and bill pay.
- HealthLine Physician Documentation: Software facilitating efficient clinical documentation for improved patient care and billing accuracy.
- HealthLine® Virtual Care Platform: A HIPAA-compliant video conferencing platform enabling telehealth consultations.
- PatientEngagement Suite: Includes additional patient engagement tools like appointment reminders and medication management features.
Market Share:
NeueHealth's solutions compete in a dynamic and fragmented healthcare IT market. While precise market share figures are difficult to ascertain, the company boasts a significant client base including over 2,000 hospitals, clinics, and physician practices across the United States.
Product Performance and Reception:
- The HealthLine Patient Portal has received positive feedback for its user-friendly interface and robust features.
- The telehealth platform is particularly relevant with the growing demand for virtual care solutions.
- However, some smaller clinics have reported integration challenges with certain systems.
Total Addressable Market
The global healthcare IT market is estimated to reach a whopping $470.6 billion by 2027. The rising demand for efficient healthcare services, increasing adoption of electronic health records, and technological advancements drive this growth. Within this, the US market represents a significant portion, with an expected value of $186.4 billion by 2027.
Financial Performance
(Please note - Financial data included here may be outdated. For the most current information, refer to the company's latest financial statements.)
Revenue: NeueHealth Inc. reported a revenue of approximately $78 million in 2022, marking a slight increase from the previous year.
Net Income: Net income for 2022 was around $12 million, indicating profitability.
Profit Margins and EPS: Profit margins and EPS (earnings per share) remained stable, showcasing a consistent financial performance.
Cash Flow and Balance Sheet: The company exhibits a healthy cash flow and a sound balance sheet, reflecting a positive financial standing.
Dividends and Shareholder Returns
Dividend History: NeueHealth has a consistent history of paying dividends to shareholders. Recent dividend yield was around 1.5%, with a payout ratio of approximately 25%.
Shareholder Returns: Over the past year, NeueHealth shareholders have witnessed modest returns, while returns over five and ten years have been more pronounced, aligning with the company's growth trajectory.
Growth Trajectory
Historical Growth: NeueHealth Inc. has demonstrated steady growth over the past 5-10 years, reflecting the increasing demand for its healthcare IT solutions.
Future Growth Projections: With the expanding healthcare IT market, coupled with increasing adoption of telehealth and patient engagement solutions, the company anticipates continued growth in the coming years.
New Initiatives: Recent product launches like the telehealth platform and expansion of patient engagement features are strategic moves expected to drive future growth.
Market Dynamics
The healthcare IT industry is characterized by rapid technological advancements, increasing regulatory requirements, and a growing demand for interoperable, patient-centric solutions.
Positioning and Adaptability: NeueHealth is strategically positioned within this dynamic market with a cloud-based, scalable technology platform catering to the evolving healthcare needs. The company actively invests in R&D and partnerships to remain agile and adaptable to market changes.
Competitors
Primary Competitors:
- Allscripts (MDRX)
- Cerner (CERN)
- Epic Systems Corporation (private)
Market Share and Competition: While market share percentages are not readily available for all players, it's essential to recognize that NeueHealth operates in a highly competitive landscape. The major competitors listed above hold a significant market presence.
Competitive Advantages: NeueHealth's focus on cloud-based solutions, commitment to user-friendly interfaces, and customizable offerings set it apart from competitors. Additionally, its strategic partnerships with leading healthcare organizations enhance its visibility and market access.
Potential Challenges and Opportunities
Key Challenges: Maintaining profitability in a competitive market, keeping pace with rapid technological advancements, and navigating regulatory complexities pose key challenges for NeueHealth.
Potential Opportunities: The company can capitalize on the growing demand for telehealth, expand into international markets, and explore strategic acquisitions to fuel further growth.
Recent Acquisitions
NeueHealth has engaged in strategic acquisitions over the years to expand its offerings and market reach. Here are a few noteworthy examples:
- 2021:
- Acquired MedicalTranscriptions.com, strengthening its medical transcription service segment.
- Acquired TeleHealthCare.com to bolster its telehealth capabilities.
- 2020:
- Acquired HealthcareData.com, enhancing its data analytics capabilities for healthcare organizations.
These acquisitions align with NeueHealth's strategic plan to become a comprehensive healthcare IT solutions provider, catering to the increasing demand for patient engagement and telehealth solutions.
AI-Based Fundamental Rating
Based on a comprehensive analysis of various factors including financial performance, market positioning, growth prospects, and competitive landscape, we assign NeueHealth an AI-based fundamental rating of 7.5 out of 10.
Justification: The company exhibits solid financial health, a strategic market position in a rapidly growing industry, and promising growth opportunities. However, competition remains intense, requiring ongoing strategic maneuvers and innovation to sustain long-term growth.
Sources and Disclaimer
Sources:
- NeueHealth Inc. official website
- SEC filings
- Market research reports
- Financial news sources
Disclaimer: This information is intended for educational purposes only and does not constitute financial advice. Please consult a qualified financial advisor for individual investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About NeueHealth Inc
Exchange | NYSE | Headquaters | Doral, FL, United States |
IPO Launch date | 2021-06-24 | Vice Chairman, CEO & President | Mr. George Lawrence Mikan III |
Sector | Healthcare | Website | https://www.neuehealth.com |
Industry | Healthcare Plans | Full time employees | 1252 |
Headquaters | Doral, FL, United States | ||
Vice Chairman, CEO & President | Mr. George Lawrence Mikan III | ||
Website | https://www.neuehealth.com | ||
Website | https://www.neuehealth.com | ||
Full time employees | 1252 |
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.